Skip to main content

Advertisement

SpringerLink
Log in

Impact of Bevacizumab on Experimentally Induced Endometriotic Lesions: Angiogenesis, Invasion, Apoptosis, and Cell Proliferation

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Endometriosis is responsible for pain symptoms with great impact on the patient’s quality of life. Several medication lines have been studied aiming at its definitive treatment. Among them, angiogenesis inhibitor factors may be effective given that angiogenesis has fundamental role in the establishment and growth of endometriotic lesions. In this study, we investigated the influence of bevacizumab, anti-factor drug of endothelial growth (anti-VEGF), used at two different dosages, in experimental endometriosis induced in rats. After the induction of endometriosis lesions in rats, they were divided in 3 groups: control group, no treatment, and two other groups were treated with different dosages of the same medication for 4 weeks. At the end of the treatment, endometriotic lesions were removed and evaluated regarding area of lesions, presence of endometrial tissue in microscopy, positivity for anti-VEGF antibody in immunohistochemistry, and gene expression of Pcna, Mmp9, Tp63, and Vegfa. Bevacizumab acted by reducing the area of lesions in the groups that received medication (p = 0.002) and reducing gene expression to Tp63 in lesions (p = 0.04). There was no significant result in other evaluations. We observed that there was significant reduction of the area of lesions among groups, suggesting that bevacizumab has a positive effect on disease control. The gene expression of Tp63 was significantly lower in the group that received high dose of the drug when compared with the other two groups; therefore, we concluded that bevacizumab acts by reducing cell proliferation and differentiation in lesions, constituting a real option for treating endometriosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Worley MJ, Welch WR, Berkowitz RS, Ng S-W. Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013;14(3):5367–79.

    Article  CAS  Google Scholar 

  2. Farquhar C. Endometriosis. BMJ. 20073;334(7587):249–53.

  3. Catenacci M, Sastry S, Falcone T. Laparoscopic surgery for endometriosis. Clin Obstet Gynecol. 2009;52(3):351–61.

    Article  Google Scholar 

  4. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12.

    Article  CAS  Google Scholar 

  5. Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, et al. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013;14(3):291–305.

    Article  CAS  Google Scholar 

  6. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927–35.

    Article  Google Scholar 

  7. Kho RM, Andres MP, Borrelli GM, Neto JS, Zanluchi A, Abrão MS. Surgical treatment of different types of endometriosis: comparison of major society guidelines and preferred clinical algorithms. Best Pract Res Clin Obstet Gynaecol. 2018;51:102–10.

    Article  Google Scholar 

  8. Liu H, Wang J, Wang H, Tang N, Li Y, Zhang Y, et al. Correlation between matrix metalloproteinase-9 and endometriosis. Int J Clin Exp Pathol. 2015;8(10):13399–404.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Groothuis PG, Nap AW, Winterhager E, Grümmer R. Vascular development in endometriosis. Angiogenesis. 2005;8(2):147–56.

    Article  CAS  Google Scholar 

  10. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction. 2006;132(3):501–9.

    Article  CAS  Google Scholar 

  11. Laschke MW, Giebels C, Nickels RM, Scheuer C, Menger MD. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am J Pathol. 2011;178(1):442–50.

    Article  Google Scholar 

  12. Laschke MW, Giebels C, Menger MD. Vasculogenesis: a new piece of the endometriosis puzzle. Hum Reprod Update. 2011;17(5):628–36.

    Article  CAS  Google Scholar 

  13. Nisolle M, Casanas-Roux F, Anaf V, Mine JM, Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril. 1993;59(3):681–4.

    Article  CAS  Google Scholar 

  14. Song W-W, Lu H, Hou W-J, Xu G-X, Zhang J-H, Sheng Y-H, et al. Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis. Int J Clin Exp Pathol. 2014;7(11):7752–9.

    PubMed  PubMed Central  Google Scholar 

  15. Machado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril. 2008;90(1):148–55.

    Article  CAS  Google Scholar 

  16. Becker CM, D’Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res. 2007;74(2–3):121–30.

    Article  CAS  Google Scholar 

  17. Hull ML, Charnock-Jones DS, Chan CLK, Bruner-Tran KL, Osteen KG, Tom BDM, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab. 2003;88(6):2889–99.

    Article  CAS  Google Scholar 

  18. Laschke MW, Menger MD. Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update. 2012;18(6):682–702.

    Article  CAS  Google Scholar 

  19. Nap AW, Griffioen AW, Dunselman GAJ, Bouma-Ter Steege JCA, Thijssen VLJL, Evers JLH, et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab. 2004;89(3):1089–95.

    Article  CAS  Google Scholar 

  20. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci. 2002;955:89–100 discussion 118, 396–406.

    Article  CAS  Google Scholar 

  21. Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther. 2006;28(11):1779–802.

    Article  CAS  Google Scholar 

  22. Ollendorf DA, Colby JA, Pearson SD. Comparative effectiveness of anti-VEGF agents for diabetic macular edema. Int J Technol Assess Health Care. 2013;29(4):392–401.

    Article  Google Scholar 

  23. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–94.

    Article  CAS  Google Scholar 

  24. Abbott FV, Hellemans KG. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res. 2000;112(1–2):177–86.

    Article  CAS  Google Scholar 

  25. Ozer H, Boztosun A, Açmaz G, Atilgan R, Akkar OB, Kosar MI. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci. 2013;20(1):26–32.

    Article  CAS  Google Scholar 

  26. Novella-Maestre E, Carda C, Noguera I, Ruiz-Saurí A, García-Velasco JA, Simón C, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009;24(5):1025–35.

    Article  CAS  Google Scholar 

  27. Rosa-e-Silva JC, Garcia SB, de Sá Rosa-e-Silva ACJ, Candido-dos-Reis FJ, Poli-Neto OB, Ferriani RA, et al. Increased cell proliferation in experimentally induced endometriosis in rabbits. Fertil Steril. 2010;93(5):1637–42.

    Article  Google Scholar 

  28. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138–40.

    CAS  Google Scholar 

  29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.

    Article  CAS  Google Scholar 

  30. Liu S, Xin X, Hua T, Shi R, Chi S, Jin Z, et al. Efficacy of anti-VEGF/VEGFR agents on animal models of endometriosis: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166658.

    Article  Google Scholar 

  31. Soysal D, Kızıldağ S, Saatlı B, Posacı C, Soysal S, Koyuncuoğlu M, et al. A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model. Balkan J Med Genet. 2014;17(2):73–80.

    Article  CAS  Google Scholar 

  32. Ricci AG, Olivares CN, Bilotas MA, Meresman GF, Barañao RI. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci. 2011;18(7):614–22.

    Article  CAS  Google Scholar 

  33. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27(8):441–7.

    Article  Google Scholar 

  34. Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Daraï E. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer. 2006;16(5):1911–7.

    Article  CAS  Google Scholar 

  35. Weigel MT, Krämer J, Schem C, Wenners A, Alkatout I, Jonat W, et al. Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):74–8.

    Article  CAS  Google Scholar 

  36. Wren JD, Wu Y, Guo S-W. A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium. Hum Reprod. 2007;22(8):2093–102.

    Article  CAS  Google Scholar 

  37. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8(2):494–501.

    PubMed  Google Scholar 

  38. Poli Neto OB, Ferreira HM, Ramalho LNZ, Rosa e Silva JC, Candido dos Reis FJ, Nogueira AA. Expression of p63 differs in peritoneal endometriosis, endometriomas, adenomyosis, rectovaginal septum endometriosis, and abdominal wall endometriosis. Arch Pathol Lab Med. 2007;131(7):1099–102.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ribeirão Preto School of Medicine, Department of Gynecology and Obstetrics, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil

    Ana Carolina Tagliatti Zani, Fernando Passador Valerio, Juliana Meola, Antonio Alberto Nogueira, Francisco José Candido-dos-Reis, Omero Benedicto Poli-Neto & Julio Cesar Rosa-e-Silva

  2. Ribeirão Preto School of Medicine, Department of Pathology and Legal Medicine, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil

    Alfredo Ribeiro da Silva

Authors
  1. Ana Carolina Tagliatti Zani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Passador Valerio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juliana Meola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alfredo Ribeiro da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Alberto Nogueira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francisco José Candido-dos-Reis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omero Benedicto Poli-Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Julio Cesar Rosa-e-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio Cesar Rosa-e-Silva.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zani, A.C.T., Valerio, F.P., Meola, J. et al. Impact of Bevacizumab on Experimentally Induced Endometriotic Lesions: Angiogenesis, Invasion, Apoptosis, and Cell Proliferation. Reprod. Sci. 27, 1943–1950 (2020). https://doi.org/10.1007/s43032-020-00213-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-020-00213-7

Keywords

Search

Navigation